Development of biosimilars in an era of oncologic drug shortages

por Li, Edward, Subramanian, Janakiraman, Anderson, Scott, Thomas, Dolca, McKinley, Jason, Jacobs, Ira A
Publicado 2015

Clinical considerations for the development of biosimilars in oncology

por Socinski, Mark A, Curigliano, Giuseppe, Jacobs, Ira, Gumbiner, Barry, MacDonald, Judith, Thomas, Dolca
Publicado 2015

Tonsilar NK Cells Restrict B Cell Transformation by the Epstein-Barr Virus via IFN-γ

por Strowig, Till, Brilot, Fabienne, Arrey, Frida, Bougras, Gwenola, Thomas, Dolca, Muller, William A, Münz, Christian
Publicado 2008

A thorough QTc study to evaluate the effects of oral rilzabrutinib administered alone and with ritonavir in healthy subjects

por Ucpinar, Sibel, Darpo, Borje, Neale, Ann, Nunn, Philip, Shu, Jin, Chu, Katherine A., Kavanagh, Marianne, Xue, Hongqi, Phiasivongsa, Pasit, Thomas, Dolca, Smith, Patrick F.
Publicado 2022

A phase I pharmacokinetics trial comparing PF‐05280586 (a potential biosimilar) and rituximab in patients with active rheumatoid arthritis

por Cohen, Stanley, Emery, Paul, Greenwald, Maria, Yin, Donghua, Becker, Jean‐Claude, Melia, Lisa Ann, Li, Ruifeng, Gumbiner, Barry, Thomas, Dolca, Spencer‐Green, George, Meng, Xu
Publicado 2016